Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase– lowering effects of garlic in patients with type 2 diabetes mellitus with obesity

References

• World Health Organization Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Geneva World Health Organization 1999 Available from http://www.who.int/diabetes/currentpublications/en/ Accessed December 14, 2012
   Google Scholar
• Ramchandran A Snehalatha C Vijay V Burden of type 2 diabetes and its complications – the Indian scenario Current Science 2002 83 1471 1476
   Web of Science ®Google Scholar
• Cowie CC Eberhardt MS Diabetes 1996: Vital Statistics Alexandria American Diabetes Association 1996
   Google Scholar
• Davidson MB Diabetes Mellitus: Diagnosis and Treatment 3rd ed NewYork Churchill Livingstone 1991
   Google Scholar
• Stratton IM Adler AI Neil HA Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 2000 321 7258 405 412 10938048
   PubMed Web of Science ®Google Scholar
• Stehouwer CD Gall MA Twisk JW Knudsen E Emeis JJ Parving HH Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death Diabetes 2002 51 4 1157 1165 11916939
   PubMed Web of Science ®Google Scholar
• Lapice E Maione S Patti L Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy non-obese people Diabetes Care 2009 32 9 1734 1736 19587368
   PubMed Web of Science ®Google Scholar
• Gabay C Kushner I Acute-phase proteins and other systemic responses to inflammation N Engl J Med 1999 340 6 448 454 9971870
   PubMed Web of Science ®Google Scholar
• Weisberg SP McCann D Desai M Rosenbaum M Leibel RL Ferrante AWJr Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 2003 112 12 1796 1808 14679176
   PubMed Web of Science ®Google Scholar
• Duncan BB Schmidt M Pankow JS Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 2003 52 7 1799 1805 12829649
   PubMed Web of Science ®Google Scholar
• Prakash MS Chennaiah S Murthy YS Anjaiah E Rao SA Suresh C Altered adenosine deaminase activity in type 2 diabetes mellitus JIACM 2006 7 114 117
   Google Scholar
• Kurtul N Pence S Akarsu E Kocoglu H Aksoy Y Aksoy H Adenosine deaminase activity in the serum of type 2 diabetic patients Acta Medica (Hradec Kralove) 2004 47 1 33 35 15168879
   PubMedGoogle Scholar
• De Fronzo RA Pharmacologic therapy for type 2 diabetes mellitus Ann Intern Med 1999 131 4 281 303 10454950
   PubMed Web of Science ®Google Scholar
• Lima LM Wiernsperger N Kraemer-Aguiar LG Bouskela E Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen Clinics (Sao Paulo) 2009 64 5 415 420 19488607
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Standards of medical care in diabetes – 2011 Diabetes Care 2011 34 Suppl 1 S11 S61 21193625
   PubMed Web of Science ®Google Scholar
• Caballero AE Delgado A Aguilar-Salinas CA The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial J Clin Endocrinol Metab 2004 89 8 3943 3948 15292331
   PubMed Web of Science ®Google Scholar
• Haffner S Temprosa M Crandall J Diabetes Prevention Program Research Group Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance Diabetes 2005 54 5 1566 1572 15855347
   PubMed Web of Science ®Google Scholar
• [No authors listed]WHO Expert Committee on Diabetes Mellitus: second report World Health OrganTech Rep Ser 1980 646 1 80
   Google Scholar
• Agarwal KC Therapeutic actions of garlic constituents Med Res Rev 1996 16 1 111 124 8788216
   PubMed Web of Science ®Google Scholar
• Yeh YY Yeh SM Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis Lipids 1994 29 3 189 193 8170288
   PubMed Web of Science ®Google Scholar
• Melzig MF Krause E Franke S Inhibition of adenosine deaminase activity of aortic endothelial cells by extracts of garlic (Allium sativum L.) Pharmazie 1995 50 5 359 361 7604070
   PubMed Web of Science ®Google Scholar
• Zeb I Ahmadi N Nasir K Aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial J Cardiovasc Dis Res 2012 3 3 185 190 22923934
   PubMedGoogle Scholar
• Ide N Lau BH Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-kappa b activation J Nutr 2001 131 Suppl 3 S1020 S1026
   Web of Science ®Google Scholar
• Williams MJ Sutherland WH McCormick MP Yeoman DJ de Jong SA Aged garlic extract improves endothelial function in men with coronary artery disease Phytother Res 2005 19 4 314 319 16041725
   PubMed Web of Science ®Google Scholar
• Lasuna (capsule) [product information]. The Himalaya Drug Company 2002 Available from http://www.himalayahealthcare.com/products/lasuna.htm#d Accessed January 5, 2013
   Google Scholar
• Trinder P Determination of blood glucose using an oxidase per-oxidase system with a non-carcinogenic chromogen J Clin Pathol 1969 22 2 158 161 5776547
   PubMed Web of Science ®Google Scholar
• Allain C Poon LS Chan CS Richmond W Fu PC Enzymatic determination of total serum cholesterol Clin Chem 1974 20 4 470 475 4818200
   PubMed Web of Science ®Google Scholar
• Trinder P Triglycerides estimation by GPO-PAP method Ann Clin Biochem 1996 6 24 27
   Google Scholar
• Burstein M Scholnick HR Morfin R Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions J Lipid Res 1970 11 6 583 595 4100998
   PubMed Web of Science ®Google Scholar
• Bairaktari ET Seferiadis KI Elisaf MS Evaluation of methods for the measurement of low-density lipoprotein cholesterol J Cardiovasc Pharmacol Therapeut 2005 10 1 45 54
   PubMed Web of Science ®Google Scholar
• Mendall MA Patel P Ballam L Strachan D Northfield TC C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study BMJ 1996 312 7038 1061 1065 8616412
   PubMed Web of Science ®Google Scholar
• Giusti G Galanti R Adenosine deaminase Bergmeyer HU Methods of Enzymatic Analysis 2nd ed New York Academic Press Inc 1974 2 1092 1099
   Google Scholar
• Jeppsson J Kobold U Barr J International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Approved IFCC reference method for the measurement of HbA1c in human blood Clin Chem Lab Med 2002 40 1 78 89 11916276
   PubMed Web of Science ®Google Scholar
• NIH/NHLBI (National Institutes of Health National Heart, Lung, and Blood Insitute) Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults Bethesda National Institutes of Health 1998 Available from http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.htm Accessed December 14, 2012
   Google Scholar
• Mannucci E Monami M Lamanna C Adalsteinsson JE Post-prandial glucose and diabetic complications: systematic review of observational studies Acta Diabetol 2012 49 4 307 314 22116350
   PubMed Web of Science ®Google Scholar
• Stumvoll M Nurjhan N Perriello G Dailey G Gerich JE Metabolic effects of metformin in non-insulin-dependent diabetes mellitus N Engl J Med 1995 333 9 550 554 7623903
   PubMed Web of Science ®Google Scholar
• DeFronzo RA Goodman AM Efficacy of metformin in patients with non-insulin dependent diabetes mellitus. The Multicenter Study Group N Eng J Med 1995 333 9 541 549
   PubMed Web of Science ®Google Scholar
• Ashraf R Alam Khan R Ashraf I Effects of garlic on blood glucose levels and HbA1c in patients with type 2 diabetes mellitus J Med Plants Res 2011 5 13 2922 2928
   Google Scholar
• Sobenin IA Nedosugova LV Filatova LV Balabolkin MI Gorchakova TV Orekhov AN Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study Acta Diabetol 2008 45 1 1 6 17823766
   PubMed Web of Science ®Google Scholar
• Robinson AC Burke J Robinson S Johnston GD Elkeles RS The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control Diabetes Care 1998 2 5 701 705 9589227
   PubMed Web of Science ®Google Scholar
• Wulffelé MG Kooy A de Zeeuw D Stehouwer CD Gansevoort RT The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review J Int Med 2004 256 1 1 14
   Web of Science ®Google Scholar
• Wu MS Johnston P Sheu WH Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients Diabetes Care 1990 13 1 1 8 2404714
   PubMed Web of Science ®Google Scholar
• Santen RJ Willin PW3rd Fajans SS Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin level Arch Intern Med 1972 130 6 833 843 5082462
   PubMedGoogle Scholar
• Pradhan AD Everett BM Cook NR Rifai N Ridker PM Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial JAMA 2009 302 11 1186 1196 19755697
   PubMed Web of Science ®Google Scholar
• Koch H P Jäger W Hysek J Körpert B Garlic and onion extracts: in vitro inhibition of adenosine deaminase Phytother Res 1992 6 1 50 52
   Web of Science ®Google Scholar